Insempra and Axxence launch alpha-ionone
Precision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
ADVERTISEMENT
About Thomas Gabrielczyk
This author has not written his bio yet.
But we are proud to say that Thomas Gabrielczyk contributed 2129 entries already.
Entries by Thomas Gabrielczyk
German-Chinese ADC collaboration
BioNTech has entered the ADC field with an exclusive license and collaboration agreement with China’s DualityBio Ltd for two antibody-drug conjugate (ADC) assets.
Nomi Biotech presents natural additive to preserve probiotics
Researchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives.
Algal enzyme synthesizes gasoline building blocks
An algal photoenzyme that synthesizes medium-chain hydrocarbons – the building blocks of gasoline – is set to boost industrial-scale production of biofuels.
LSP Dementia Fund closes at €260m
EQT Life Sciences has closed the LSP Dementia Fund at approximately €260m, 2.6-fold over the target fund size of €100m.
Secarna Pharmaceuticals partners with SciNeuro Pharmaceuticals
Antisense drug developer Secarna Pharmaceuticals and CNS expert SciNeuro Pharmaceuticals have inked an R&D and licence option contract for CNS diseases.
Hot of the press: new issue of BIOTECH Insight
The latest issue of BIOTECH Insight newsletter of Deutsche Börse in collaboration with BIOCOM AG is out, covering hot topics of the German biotech sector.
Macomics licences macrophage modulator to Ono
Edinburgh-based immuno-oncology expert Macomics Ltd has partnered with Ono Pharmaceutical to develop a macrophage-targeting antibody targetting cancer.
mbiomics GmbH cashes in €13m in Series A financing
Munich-based microbiome therapeutics specialist mbiomics GmbH has raised €13m in the first closing of Series A round led by MIG Capital.
BioIVT | Human AB Serum – Plasma-derived
Serum-supplemented cell culture media remains the gold standard for obtaining near in vivo conditions. That’s why we have expanded our product line to include GMP-grade Human AB Serum.